NEWS
Our Latest News
ARCHIMED purchases BioVendor Group, a leading global player in advanced diagnostics
Global private equity healthcare specialist ARCHIMED announces the acquisition of BioVendor Group, a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research, expanding ARCHIMED’s numerous investments in the diagnostics industry.
ARCHIMED’s BOMI Group enters new geographies and market segments through six Buy-and-Build acquisitions made over eight months
January
25,
2021
ARCHIMED buys Germany’s Zyto Group of Cancer Diagnostics companies in partnership with owners and management
January
12,
2021
ARCHIMED’s NAMSA announces key acquisition of Syntactx
January
5,
2021
ARCHIMED gives several million euros to the EURÊKA Foundation its philanthropic arm
November
25,
2020
Partnering with existing owners and management, ARCHIMED acquires majority interest in NAMSA, the world leader in medical device testing
September
1,
2020
ARCHIMED raises €1 billion for its MED Platform I Fund
August
28,
2020
368